Anabolic agents in trauma and sepsis: Repleting body mass and function

Nutrition

Volumn 14, Issue 6, 1998, Pages 554-556

  Saito, Hideaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anabolism; Growth hormone; Immunostimulation; Insulin like growth factor 1

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN; SOMATOMEDIN C;

APOPTOSIS; BIOSYNTHESIS; BODY MASS; CATABOLISM; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; DEPRESSION; FEMALE; GRIP STRENGTH; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; POLYMORPHONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SAFETY; SEPSIS; TRAUMATIC SHOCK; TREATMENT PLANNING; WOUND HEALING;

ANIMALS; CRITICAL ILLNESS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUTROPHILS; NITROGEN; PHAGOCYTOSIS; SEPSIS; WEIGHT GAIN; WOUNDS AND INJURIES;

ANIMALIA;

EID: 0032101158     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(98)00049-5     Document Type: Conference Paper

References (30)

1. Ward H.C., Halliday D., Sim A.J.W. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg. 206:1987;56.
2. Ponting G.A., Ward H.C., Halliday D., Sim A.J.W. Protein and energy metabolism with biosynthetic human growth hormone in patients on full intravenous nutritional support. JPEN. 14:1990;437.
3. Jiang Z.M., He G.Z., Zhang S.Y., et al. Low dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg. 210:1989;513.
4. Jeevanandam M., Ali M.R., Holaday N.J., Petersen S.R. Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. JPEN. 19:1995;137.
5. Gottardis M., Benzer A., Koller W., Luger T.J., Puhringer F., Hackl J. Improvement of septic syndrome after administration of recombinant human growth hormone. J Trauma. 31:1991;81.
6. Voerman H.J., van Schijndel R.J., Groeneveld A.B., et al. Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg. 216:1992;648.
7. Petersen S.R., Holaday N.J., Jeevanandam M. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma. 36:1994;726.
8. Koea J.B., Breier B.H., Douglas R.G., Gluckman P.D., Shaw J.H. Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis. Br J Surg. 83:1996;196.
9. Dahn M.S., Lange P., Jacobs L.A. Insulin-like growth factor 1 production is inhibited in human sepsis. Arch Surg. 123:1988;1409.
10. Belcher H.J.C.R., Mercer D., Judkins K.C., et al. Biosynthetic human growth hormone in burned patients a pilot study . Burns. 15:1989;99.
11. Roth E., Valentini L., Semsroth M., et al. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J Trauma. 38:1995;136.
12. Jenkins R.C., Ross R.J. Acquired growth hormone resistance in catabolic states. Baillieres Clin Endocrinol Metab. 10:1996;411.
13. Donaghy A.J., Baxter R.C. Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. Baillieres Clin Endocrinol Metab. 10:1996;421.
14. Young L, Byrne T, Wilmore D. Organ specific nutrients and associated therapy: growth factors-growth hormone. In: Wilmore D, Carpentier Y, eds. Metabolic support of the critically ill patients. Update in intensive care and emergency medicine, Series 17. Vincent JL, ed. Berlin: Springer-Verlag, 1993:254.
15. Inaba T., Saito H., Fukushima R., et al. The effects of growth hormone and insulin-like growth factor 1 (IGF-1) on hepatic IGF-1-mRNA, plasma IGF-1 and nitrogen excretion in gastrectomized rats with liver cirrhosis. Clin Nutr. 15:1996;321.
16. Inaba T., Saito H., Fukushima R., et al. Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats. JPEN. 20:1996;325.
17. Inaba T., Saito H., Fukushima R., et al. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury. JPEN. 21:1997;55.
18. Goeters C., Mertes N., Tacke J., et al. Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Effect on metabolic and hormonal patterns. Ann Surg. 222:1995;646.
19. Wolf S.E., Barrow R.E., Herndon D.N. Growth hormone and IGF-1 therapy in the hypercatabolic patient. Baillieres Clin Endocrinol Metab. 10:1996;447.
20. Pichard C., Kyle U., Chevrolet J.C., et al. Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation a prospective, randomized, controlled study . Crit Care Med. 24:1996;403.
21. Gilpin D.A., Barrow R.E., Rutan R.L., Broemeling L., Herndon D.N. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg. 220:1994;19.
22. Kelley K.W. The role of growth hormone in modulation of the immune response. Ann N Y Acad Sci. 594:1990;95.
23. Wiedermann C.J., Reinisch N., Kahler C., Braunsteiner H. Regulation of myeloid phagocyte development and function by growth hormone a review . J Pediatr Endocrinol. 6:1993;85.
24. Saito H., Inoue T., Fukatsu K., et al. Growth hormone and the immune response to bacterial infection. Horm Res. 45:1996;50.
25. Saito H., Taniwaka K., Fukushima R., et al. Growth hormone treatment stimulates immune responsiveness after abdominal surgery. Clin Nutr. 9:(suppl):1990;16.
26. Kudsk K.A., Mowatt-Larssen C., Bukar J., et al. Effect of recombinant human insulin-like growth factor 1 and early total parenteral nutrition on immune depression following severe head injury. Arch Surg. 129:1994;66.
27. Inoue T., Saito H., Fukushima R., et al. Growth hormone and insulin-like growth factor 1 enhance host defense in a murine sepsis model. Arch Surg. 130:1995;1115.
28. Inoue T., Saito H., Hashiguchi Y., et al. Growth hormone and insulin-like growth factor 1 augment Escherichia coli-killing activity of murine peritoneal exudative cells. Shock. 6:1996;345.
29. Inoue T., Saito H., Matsuda T., et al. Effects of growth hormone and insulin-like growth factor 1 on PMN phagocytosis and monocyte HLA-DR expression in postoperative patients. Clin Nutr. 16:(suppl 2):1997;13.
30. Matsuda T., Saito H., Tsuno N. Growth hormone (GH) inhibits human neutrophil cell death in vitro. JPEN. 15:(suppl):1997;21.